Plain-language definitions grounded in the clinical and regulatory literature.
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Hormone
What it isA hormone your brain produces at night that signals it’s time to sleep. Production ramps up when it gets dark and drops off in the morning.
Why it mattersUnderstanding melatonin helps explain why light at night disrupts sleep and why shift workers struggle with their sleep schedules.
Think of it like thisThink of melatonin as your brain’s dimmer switch—it doesn’t knock you out like a sleeping pill, but it gradually turns down your alertness as bedtime approaches.
An indolamine hormone (N-acetyl-5-methoxytryptamine) synthesized primarily in the pineal gland from serotonin via arylalkylamine N-acetyltransferase (AANAT) and acetylserotonin O-methyltransferase (ASMT).
MechanismMelatonin synthesis is controlled by the suprachiasmatic nucleus (SCN) via a multisynaptic pathway through the paraventricular nucleus, intermediolateral column, and superior cervical ganglion. Norepinephrine release activates pinealocyte β1-adrenergic receptors, triggering cAMP-dependent AANAT activation. Light exposure suppresses this pathway via ipRGC input to the SCN.
Scientific ConsensusMelatonin is the primary hormonal signal of darkness in mammals. Its phase-shifting properties are well-established, with the phase response curve showing advances with evening administration and delays with morning administration.
Active DebateWhether melatonin supplementation provides meaningful sleep benefits for healthy adults remains contested. Optimal dosing (physiological 0.3mg vs pharmacological 3-10mg) and timing protocols lack consensus. The extent to which melatonin’s effects are direct sleep-promoting vs indirect circadian phase-shifting is debated.
Emerging ResearchMT1/MT2 receptor-selective agonists for targeted chronotherapy; melatonin’s role in mitochondrial function and antioxidant defense; potential oncostatic properties via immune modulation.
Key ResearchArendt’s 2005 review established melatonin as the primary darkness signal. Pandi-Perumal et al. (2006) expanded understanding of receptor subtypes. Claustrat et al. (2005) documented the synthesis pathway. Recent work by Sletten et al. (2018) clarified phase response curves.
— Definitive review establishing melatonin as darkness signal and chronobiotic
— Comprehensive receptor pharmacology and signaling pathways
— Synthesis pathway from tryptophan and physiological roles
Sack, R.L. et al. (2007). Circadian rhythm sleep disorders: Part II. Sleep, 30(11), 1484-1501.
— AASM clinical guidelines for melatonin in circadian disorders
— Established melatonin phase response curve for chronotherapy
— DLMO measurement methodology and circadian phase assessment
— Melatonin free radical scavenging beyond chronobiotic effects
— Modern clinical applications and formulation considerations
Sleep disorders, PTSD, and the invisible wounds of service can feel isolating. If you or someone you know is in crisis or experiencing thoughts of self-harm, help is available right now. The Veterans Crisis Line provides free, confidential support 24 hours a day, 7 days a week to veterans, service members, and their families.
If you are in crisis or experiencing thoughts of self-harm, call the Veterans Crisis Line at